The effect of enoxaparin-containing irrigation fluid during cataract surgery on post-operative inflammation in patients with diabetes

Authors
Category Primary study
Registry of TrialsANZCTR
Year 2013
INTERVENTION: Arm 1; Drug: Enoxaparin. It is administered during the cataract surgery. The mode of the administration is intraocular infusion. Enoxaparin 40 mg/500 ml in Balanced Salt Solution Other name: clexane (Aventis) CONDITION: post‐operative inflammation after cataract surgery in patients with diabetes PRIMARY OUTCOME: Anterior segment inflammation. ; This is assessed by slit‐lamp biomicroscopy. SECONDARY OUTCOME: Anterior segment inflammation ; This is assessed by slit‐lamp biomicroscopy. INCLUSION CRITERIA: The study included non‐insulin‐dependent diabetes mellitus (NIDDM) patients that had moderate non‐proliferative diabetic retinopathy (NPDR) according to Early Treatment Diabetic Retinopathy Study (ETDRS) and had grade 2‐3 nuclear cataracts based on the classification of Lens Opacity Classification System III (LOCS III)
Epistemonikos ID: 9d2c97d826855c44e56a61fab5727d7d34031569
First added on: Aug 22, 2024